Chronic hyperglycemia has adverse effects on B cell function. We investigated the possible role of advanced glycosylation end products (AGEs) in glucotoxicity. Rat islets were cultured at different glucose concentrations for 1-6 weeks in RPMI 1640. Culture was performed with or without aminoguanidine (AG), which is known to prevent AGE formation in other tissues. AGE-associated fluorescence (370 nm excitation and 440 nm emission) progressively increased during 6 weeks of culture at 38 mM, but not at 11 or 5.5 mM, glucose. The increase in fluorescence was significantly inhibited by AG. The effects of AG on insulin secretion were tested directly after the culture period as well as after a wash-out period of continued culture at 11 mM glucose in the absence of AG. The presence of AG during culture for 1 week at 38 mM glucose failed to affect basal release at 3.3 mM glucose or stimulated release at 27 mM glucose. AG was ineffective whether tested directly after the culture period or after wash-out. When the same culture conditions were prolonged for 6 weeks, culture with AG suppressed basal and stimulated insulin secretion after the culture period. However, after wash-out, previous AG treatment enhanced the insulin response to 27 mM glucose 2-fold compared to culture without AG (P Ͻ 0.01). Proinsulin and total protein biosyntheses in 38 mM glucose-cultured islets were increased 40 -80% by AG after 6 weeks of culture, and this effect was similar after wash-out. Preproinsulin messenger RNA levels were significantly increased (P Ͻ 0.05) after 6 weeks of culture with AG. N G -Methyl-L-arginine, a nitric oxide synthase inhibitor, failed to mimic the effects of AG. The results indicate that the time-dependent beneficial effects of AG on insulin secretion and biosynthesis are related to inhibitory effects on AGE formation and that accumulation of islet AGEs could be important for glucotoxicity toward B cells. (Endocrinology 138: 273-280, 1997) T HE DIABETIC state impairs B cell function in both animals (1, 2) and man (3, 4). Evidence indicates that both hyperglycemia (2) and elevated FFA (5) are important for decreased function. One effect of hyperglycemia is indirect and coupled to excessive stimulation (6). This indirect effect of hyperglycemia is rapidly induced and rapidly reversible. However, direct effects of glucose (glucotoxicity), with longer latency of induction and reversal, are also possible and may be suspected because of the known potency of chronic hyperglycemia to cause diabetic complications.
T HE DIABETIC state impairs B cell function in both animals (1, 2) and man (3, 4) . Evidence indicates that both hyperglycemia (2) and elevated FFA (5) are important for decreased function. One effect of hyperglycemia is indirect and coupled to excessive stimulation (6) . This indirect effect of hyperglycemia is rapidly induced and rapidly reversible. However, direct effects of glucose (glucotoxicity), with longer latency of induction and reversal, are also possible and may be suspected because of the known potency of chronic hyperglycemia to cause diabetic complications.
The mechanisms by which chronic hyperglycemia causes diabetic complications, such as retinopathy, neuropathy, and nephropathy, are in part related to nonenzymatic glycation and its sequelae. Hyperglycemia gives rise to nonenzymatic glycation of proteins and other molecules. Nonenzymatic glycation alters the physical properties of key molecules inside and outside of cells. This could lead to dysregulation of important cellular processes. Glycated molecules can be altered further by the formation of advanced glycosylation end products (AGEs). This formation may have serious negative effects. AGEs have thus been associated with cellular damage in microvascular complications of diabetes (7) .
The effects of aminoguanidine (AG) constitute major evidence for the importance of AGEs in diabetic complications. AG is a nucleophilic hydrazine compound that potently inhibits AGE formation (8, 9) . Beneficial effects of AG on diabetic complications have been reported in vivo and in vitro (10 -13) and are associated with inhibitory effects on AGE formation (14 -16) .
It is not known whether AGEs are formed in pancreatic islets or to which extent AGEs influence pancreatic B cells. Evidence against an important role for AGEs comes from observations that AG adversely affects insulin release in rat pancreatic islets (14, 17) . However, in the previous studies islets were either acutely exposed to AG (14) or cultured for a only short period (2 days) with AG (17) . From current knowledge of the time course of AGE formation, a much longer exposure time is needed to demonstrate AGE effects and reversal thereof by AG (14 -16) . Also, a beneficial effect of AG related to its effect on AGEs could be overshadowed by a negative effect related to the drug per se.
We aimed to test whether the formation of islet AGEs is of importance for negative effects of high glucose on B cell function. Specifically, we wished to test 1) whether high glucose induces the formation of AGEs in pancreatic islets, 2) whether AG affects AGE formation in pancreatic islets, and 3) whether long term exposure to AG in high glucosecultured islets is beneficial for B cell function.
For these purposes, we assessed AGE formation in islets by fluorescence and measured the effects of AG on this parameter. Furthermore, we evaluated the effects of AG on insulin secretion, insulin biosynthesis, and insulin messenger RNA (mRNA) from high glucose-cultured rat islets. We reasoned that AGE-related effects of AG would affect that part of B cell dysfunction that is not rapidly reversible; therefore, B cell functional parameters were evaluated after an overnight wash-out period. A wash-out period also served to eliminate short term negative effects of AG per se. To evaluate the participation of a recently demonstrated effect of AG on NO synthase (18, 19) , we also tested the effects of N G -methyll-arginine (L-NMA), a potent NO synthase inhibitor, on insulin secretion.
Materials and Methods Materials
AG, L-NMA, arginine hydrochloride, isobutylmethylxanthine, Histopaque, and PBS were purchased from Sigma Chemical Co. (St. Louis, MO). l- [4,5- 3 H]Leucine (62 Ci/mmol) was from Amersham International (Amersham, Aylesbury, UK). Undiluted guinea pig antiporcine insulin serum was obtained from ICN ImmunoBiologicals (Lisle, IL). Protein A-Sepharose CL-4B, Sephadex G-50 columns (nick column), and Dextran T-70 were purchased from Pharmacia (Uppsala, Sweden). Collagenase, ribonuclease A (RNase A), and RNase T1 were obtained from Boehringer Mannheim (Mannheim, Germany). [
35 S]UTP (1082 Ci/ mmol) was purchased from DuPont-New England Nuclear (Boston, MA). Riboprobe Gemini II Core System, pGEM-3Zf(ϩ), herring sperm DNA, RQ1 deoxyribonuclease I, and restriction enzymes (EcoRI and XbaI) were obtained from Promega Biotec (Madison, WI). GF/C filters were purchased from Whatman International (Maidstone, UK). RPMI 1640 medium, penicillin, streptomycin, and FCS were obtained from Life Technologies (Grand Island, NY). Tissue culture flasks were purchased from Nunc (Copenhagen, Denmark).
Animals
Female Wistar rats were obtained from B&K Universal (Stockholm, Sweden). At the time of experiments they weighed between 150 -250 g. They had free access to tap water and a standard pelleted diet. They were exposed to a 12-h light (0600 -1800 h), 12-h dark cycle. The experimental protocols were approved by the Stockholm ethical committee for research on animals.
Isolation of islets
Animals were killed by decapitation, and pancreatic islets were isolated by collagenase digestion as previously described (20) . Collagenase was injected into the common bile duct at a concentration of 2 mg/ml in 10 ml Hanks' solution containing 5.5 mm glucose. The pancreas was digested at 37 C for 20 min. The islets were partly separated from exocrine tissue using gradient centrifugation (700 ϫ g, 20 min, 4 C) in Histopaque. Islets were transferred to RPMI 1640 medium containing 11 mm glucose, antibiotics (100 U/ml penicillin and 100 g/ml streptomycin) and 10% FCS. Islets were cultured free floating at 37 C with an atmosphere of 5% CO 2 -95% air for 1-2 days (primary culture) to remove exocrine or other tissues.
Islet culture
After the period of primary culture, islets were selected under a stereomicroscope and transferred into 260-ml tissue culture flasks containing RPMI 1640 with the glucose concentrations described below and with or without AG (0.1 or 1 mm). Before being added to the culture medium, AG was dissolved in redistilled water at acidic condition (pH 3.0) and brought to the same pH as the culture medium (14) . In one series of experiments, 0.1 mm L-NMA was used instead of AG. Islets were cultured for 1-6 weeks. Culture medium was exchanged every second day. At the end of a 1-or 6-week culture period, some islets of each group were cultured for an additional 24 h in RPMI with 11 mm glucose but without AG or L-NMA (wash-out period).
Measurement of AGE-associated fluorescence
Islets were cultured as described above in RPMI medium containing 5.5, 11, or 38 mm glucose with or without AG. After culture, islets (20 for each determination) were washed 3 times in PBS, then sonicated in 300 l redistilled water. The sonicates were centrifuged at 10,000 ϫ g for 10 min at 4 C, and fluorescence was measured in the supernatants, using excitation at 370 nm and emission at 440 nm (21) by SPEX-1681 0.22-m spectrometer (SPEX industries, Edison, NJ).
Islet volume
In some experiments islets cultured under different conditions were randomly selected, and perpendicular diameters were measured under a stereomicroscope. Diameters were averaged, and islet volume was calculated by the formula: islet volume (nl) ϭ 4r 3 /3 ϫ 10 Ϫ6 (r ϭ radian, microns) (22) .
Insulin release
After the culture period, islets were preincubated at 37 C for 30 min in Krebs-Ringer bicarbonate (KRB) medium (23) , pH 7.4, supplemented with 10 mm HEPES, 0.2% BSA (fraction IV, Sigma Chemical Co.), and 3.3 mm glucose. Islets were selected after preincubation in batches of three islets in 300 l KRB containing either 3.3 or 27 mm glucose and, in some experiments, other additions. Final incubations were then carried out at 37 C for 60 min in a shaking water bath and an atmosphere of 95% O 2 -5% CO 2 . At the end of incubations, aliquots of the incubation medium were removed for assay of insulin concentrations. Islets that had been exposed to 3.3 mm glucose in final incubations were retrieved for the determination of islet insulin content.
Proinsulin and total protein biosynthesis
After culture, groups of 10 islets were incubated in 100 l KRB medium containing 50 Ci/ml l- [4,5- 3 H]leucine and 27 mm glucose. Incubations were carried out at 37 C for 2 h in 95% O 2 -5% CO 2 without shaking. The medium containing radioactive leucine was then carefully removed, and the islets were washed three times with Hanks' solution containing 10 mm nonradioactive leucine. The washed islets were sonicated in 200 l redistilled water (twice for 10 sec using a model B-12 sonifier at setting 4, Branson Ultrasonics Corp., Danbury, CT). The sonicates were centrifuged at 10,000 ϫ g for 10 min at 4 C, and the supernatants were used for subsequent analysis. Proinsulin-insulin biosynthesis was measured by immunoprecipitation with undiluted antiinsulin serum in excess. Separation of bound from free insulin was achieved with protein A-Sepharose CL-4B, as previously described (24) . Total protein synthesis was assessed from measurements of the radioactivity in the 10% trichloroacetic acid-precipitable fraction of the sonicates.
Total RNA and preproinsulin mRNA
Total RNA was prepared from 30 islets cultured in each condition as described by Chomczynski and Nicoletta (25) . The total RNA content of the extracts was measured by spectrophotometry (1A OD260 ϭ 40 g/ml). The quantification of preproinsulin mRNA was achieved by a solution hybridization assay using a RNA probe radiolabeled with [
35 S]UTP (26) . An in vitro synthesized 58-bp oligonucleotide corresponding to the last part of exon 3 of the rat preproinsulin II gene and flanked by BamHI and KpnI restriction sites was inserted into pGEM-3Zf(ϩ). The resulting vector, prINS2, was linearized by EcoRI and transcribed in vitro with SP6 RNA polymerase in the presence of 3 mol/L [ 35 S]UTP for synthesis of the probe. Unlabeled sense RNA was obtained by transcription with T7 RNA polymerase after linearization with XbaI. The DNA template was removed by RQ1 deoxyribonuclease I, and transcripts were separated from unincorporated nucleotides on nick columns. Three serial dilutions of each RNA sample in 20 l 0.2 ϫ SET [1 ϫ SET contains 1.0% SDS, 20 mm Tris-HCl (pH 7.5), and 10 mm EDTA] were mixed with 20 l of 2 ϫ hybridization solution (20,000 cpm probe, 1.2 m NaCl, 8 mm EDTA, 1.5 mm dithiothreitol, 50% formamide, and 40 mm Tris-HCl, pH 7.5). After hybridization at 70 C for 18 h, the samples were treated with 40 g RNase A and 100 U RNaseT1 in the presence of 100 g herring sperm DNA for 60 min at 37 C in a volume of 1 ml. Protected probe was precipitated with 100 l 100% trichloroacetic acid. Precipitates were collected on glass fiber filters (GF/C), and the radioactivity was counted in a scintillation counter. Parallel hybridizations with increasing amounts of unlabeled sense RNA allowed construction of a standard curve. The amount of preproinsulin mRNA was calculated by comparison to the standard curve, and results were expressed as picograms of preproinsulin mRNA per g total RNA.
Insulin assay
Insulin was measured by RIA using rat insulin as standard, monoiodinated porcine insulin as tracer, and antibody raised in our laboratory against porcine insulin. Antibody-bound insulin was separated from free insulin using Dextran T70-coated charcoal (27) . For the determination of islet insulin contents, three islets were transferred into 200 l acid-ethanol (0.18 m HCl in 95% ethanol). Insulin was extracted overnight at 4 C after sonication as previously described (28) .
Presentation of results
All results are expressed as the mean Ϯ sem. Analysis between groups was carried out as appropriate by Student's unpaired t test or one-way ANOVA with Student-Newman-Keuls' test. P Ͻ 0.05 was considered significant.
Results

Effects of glucose concentration during culture on subsequent insulin secretion
Islets cultured at 11 or 38 mm glucose retained significant responsiveness to glucose after both 1 and 6 weeks of culture (Table 1, lines 1-8 ). The response in absolute terms to 27 mm glucose postculture, however, was reduced in islets cultured at 38 mm glucose relative to that in islets cultured at 11 mm glucose. This difference was especially apparent after an overnight wash-out period ( [1] [2] [3] [4] . Such a tendency was seen when islets were cultured at both 11 and 38 mm glucose.
Islet survival and islet volume
Data on islet survival are given in the text only. Islet survival after 6 weeks of culture was high under all experimental conditions (80.9% in 11 mm glucose, 78.0% in 11 mm glucose with 0.1 mm AG, 80.9% in 38 mm glucose, 81.9% in 38 mm glucose with 0.1 mm AG, and 83.7% in 38 mm glucose with 1 mm AG, respectively; mean of three experiments).
Islet volume was increased by high glucose during culture (Table 2) . Although mean values of islet volumes were somewhat larger after AG, there was not a significant effect (P Ͼ 0.3).
AGEs-associated fluorescence (Fig. 1) The presence of AGEs was estimated by fluorescence measurements. After 1 week of culture, fluorescence did not differ among 5.5, 11, or 38 mm glucose-cultured islets. AG did not affect fluorescence under these conditions. Between 1 and 3 weeks, fluorescence markedly increased in islets cultured at 38 mm glucose compared with that in 5.5 or 11 mm glucose-cultured islets. The fluorescence in 38 mm glucosecultured islets increased further after 6 weeks of culture. The increase in fluorescence was significantly (P Ͻ 0.01) diminished by 0.1 and 1 mm AG.
Effects of AG on insulin accumulation in culture medium
The presence of AG during culture lowered insulin concentrations in high glucose culture medium to a moderate extent ( Table 3 ). The effect seemed dose dependent, as 1 mm AG exerted a more pronounced effect than 0.1 mm. The inhibitory effect was not appreciably altered by the time of exposure to AG (1, 3, or 6 weeks; Table 3 ).
Effects of 1 week of AG treatment on insulin release
The effects of AG on glucose-induced insulin secretion were tested before as well as after a 24-h wash-out period in the absence of the drug. After the wash-out, culture with AG for 1 week together with 11 mm glucose failed to affect subsequent glucose-induced insulin secretion (ϩ53 Ϯ 56% increment of release at 3.3 mm glucose; ϩ21 Ϯ 9% increment of release at 27 mm glucose). Similarly, the previous presence Groups of islets were cultured in RPMI 1640 containing either 11 or 38 mM glucose. Insulin release in response to 3.3 or 27 mM glucose was measured in 60-min final incubations after each culture period or after wash-out (culture for another 24 h with 11 mM glucose). Data are the mean Ϯ SEM of 10 -20 observations. a P Ͻ 0.01 vs. 11 mM glucose-cultured islets. b P Ͻ 0.01 vs. before wash-out.
of AG together with 38 mm glucose was without a significant effect on subsequent insulin secretion (Ϫ13 Ϯ 1% increment of release at 3.3 mm glucose; ϩ4 Ϯ 12% increment of release at 27 mm glucose). A wash-out period did not have any clear effect of previous AG treatment (Fig. 2, upper graphs) .
Effects of 6 weeks of AG treatment on insulin release
The presence of AG during 6 weeks of culture failed to positively affect insulin secretion. There was, in fact, a negative influence on release at 3.3 mm glucose after culture with both 11 mm glucose (Ϫ17 Ϯ 9%) and 38 mm glucose (Fig. 3) .
Release at 27 mm glucose was not significantly inhibited after AG and 11 mm glucose treatment (Ϫ16 Ϯ 7%), whereas it was inhibited after AG and 38 mm glucose treatment (Fig.  3) . Under the same conditions, AG tended to inhibit arginineand isobutylmethylxanthine-induced insulin secretion (Fig. 3) .
The effects of AG after wash-out are shown in Fig. 2 , lower graphs. When cocultured with 11 mm glucose, AG did not affect basal or glucose-stimulated insulin release after washout. In contrast, when AG was cocultured with 38 mm glucose, both basal and glucose-stimulated insulin release were markedly and significantly increased.
Effects of AG on proinsulin and total protein biosynthesis
Six weeks of culture with 38 mm glucose enhanced both proinsulin and total protein synthesis relative to culture with 11 mm glucose (Fig. 4, upper graphs) . AG enhanced both proinsulin synthesis and total protein synthesis in 38 mm, but not in 11 mm, cultured islets. A wash-out period eliminated the enhancing effect of 38 vs. 11 mm glucose-cultured islets on biosynthesis (Fig. 4, lower graphs) . However, the effect of previous exposure to AG persisted with regard to both proinsulin and total protein synthesis.
Effects of AG on total RNA and preproinsulin mRNA
The total RNA content in 6-week 38 mm glucose-cultured islets was 2.8 Ϯ 0.39 g/30 islets and significantly (P Ͻ 0.05) higher than that in 11 mm glucose-cultured islets (1.69 Ϯ 0.14 g/30 islets). This increase was not significantly affected by previous AG treatment (2.71 Ϯ 0.42 g/30 islets in 0.1 mm AG and 1.9 Ϯ 0.24 g/30 islets in 1 mm AG).
Preproinsulin mRNA was also measured at the end of a 6-week culture period (Fig. 5) . Preproinsulin mRNA was expectedly higher after culture with 11 or 38 mm glucose than after culture with 5.5 mm glucose. The coexistence of AG with 38 mm glucose enhanced levels of preproinsulin mRNA. The increase was 53% with 0.1 mm AG and 94% with 1 mm AG. 
Effects of AG on islet insulin content
Before wash-out, previous AG treatment failed to significantly affect islet insulin content (Table 4 ). The lack of effect was seen after both 1 and 6 weeks of culture and in the presence of both 11 and 38 mm glucose. The effect of a wash-out period was to increase insulin content in islets previously cultured with AG and 38 mm glucose.
Effects of L-NMA on insulin release
After 1 week of treatment with L-NMA, stimulated insulin release from 11 mm glucose-cultured islets was suppressed (from 10.4 Ϯ 1.03 to 4.61 Ϯ 0.41 ng/islet⅐60 min; P Ͻ 0.001), as was basal secretion from 38 mm glucose-cultured islets (from 3.33 Ϯ 0.29 to 2.17 Ϯ 0.12 ng/islet⅐60 min; P Ͻ 0.001). Six weeks of culture with L-NMA and 38 mm glucose led to increased basal insulin release (from 1.09 Ϯ 0.08 to 2.31 Ϯ 0.37 ng/islet⅐60 min; P Ͻ 0.05), but had no effect on stimulated insulin release. No enhancement of insulin release was observed following previous L-NMA treatment after wash-out of islets cultured for a period of 1 or 6 weeks.
Discussion
The negative effects of hyperglycemia can readily be demonstrated in vivo and subsequently in vitro (2, 4, 5) . It has proven more difficult to induce negative effects by high glucose in vitro. This partial discrepancy is probably not due to the absence of a "toxic" effect of glucose in vitro, but, rather, to a different balance between positive and negative effects of glucose in vivo vs. in vitro. Glucose is normally the main stimulator of B cell secretion, biosynthesis, and replication. Some of those stimulatory effects undoubtedly persist even under conditions when negative effects overshadow positive ones. The positive effects of glucose may be stronger in isolated islets in vitro than during in vivo conditions because of the potential diffusion problem during culture. Hence, oxygenation of the interior of islets may not be optimal under these conditions (29) . High glucose could then, by acting as substrate for glycolysis, partly substitute for decreased aerobic metabolism. Such a mechanism may explain the larger islets (volume and RNA) after culture with 38 mm glucose than with lower glucose concentrations.
Nevertheless, our results indicate that B cell secretory potential was decreased after culture with high glucose. Hence, although a fold increase in secretion due to 27 mm glucose was not affected, the absolute insulin responses were decreased after culture with 38 vs. 11 mm glucose. Notably, this decrease in insulin response was most apparent after washout. This indicates that the decrease reflects a lasting negative effect of high glucose exposure.
Two lines of evidence support a role for AGE formation on B cell function. The first one pertains to fluorescence measurements. These measurements document a time-and glucose-dependent increase in islet fluorescence during conditions of measurement that have, in other tissues, been shown to reflect the contents of AGE. Furthermore, increased fluorescence could partly be inhibited by AG. The second line of evidence pertains to effects of AG on B cell function, and these effects are discussed below.
Both inhibitory and stimulatory effects of AG were observed. The inhibitory effects of AG on insulin release under some conditions are in line with previous reports. Inhibition by AG was thus found during short term incubation with the drug (14) or after 2 days of islet culture with AG (17) . It has been proposed that an inhibitory effect of AG could be due to intracellular acidification by the drug (14) . However, the precise mechanism behind inhibition has not been elucidated.
The stimulatory effects of AG on insulin secretion were apparent after a wash-out procedure that consisted of an additional 24-h culture period at 11 mm glucose in the absence of the drug. The stimulatory effect of AG on basal and glucose-induced insulin secretion was dependent on the period of high glucose exposure preceding wash-out. The stimulatory effect of previous AG treatment was thus apparent after 6 weeks, but not after 1 week, of culture. We interpret the wash-out effect to mean that a long term stimulatory effect by AG can be unmasked by removing a negative effect of ambient AG on secretion. Islets not subjected to a wash-out period were indeed washed in KRB before final incubations. However, this procedure most likely did not remove AG completely from islets due to a delay in diffusion of the drug from the interior of islets and cells.
The beneficial effects of AG on protein biosynthesis were also apparent in 6-week high glucose-cultured islets. In contrast to the effects of AG on insulin secretion, an enhancing effect on [ 3 H]leucine accumulation into proinsulin and total protein synthesis was apparent both before and after wash-out. A beneficial effect of AG on insulin biosynthesis agrees well with our data on the islet content of preproinsulin mRNA obtained immediately after culture. Thus, previous exposure to AG markedly increased the islet content of preproinsulin mRNA.
The available evidence indicates that the beneficial effects of AG on insulin secretion and biosynthesis are due to prevention of AGE formation in islets. A multitude of studies have shown that AG prevents the formation of AGE in other tissues and that such effects prevent tissue damage (10 -13) . Furthermore, our assessment of AGE formation in islets indicates that AG inhibits AGE formation in islets. Moreover, our data argue against the alternative explanation, that AG exerts its stimulatory effects through inhibition of nitric oxide (NO) synthase. The time dependency for the stimulatory effects of AG speaks against involvement of NO synthase, as inhibitory effects of AG on this enzyme are immediate and   FIG. 3 . Effects of AG on insulin release from 6-week 38 mM glucose-cultured islets in response to various secretagogues. Insulin release was measured as described in Fig. 2 . Data are the mean Ϯ SEM of 10 observations. *, P Ͻ 0.05 vs. the value without AG. not time dependent (18, 19) . Also, the effects of AG on insulin biosynthesis persisted after a 24-h wash-out period. Furthermore, a specific inhibitor of NO synthase, present during 6 weeks of culture, failed to reproduce the effects of AG.
Granted that the beneficial (stimulatory) effects of AG are linked to the prevention of AGE formation, it is not known which aspects of formation exert negative effects on B cell function. Multiple proteins of importance for the secretory process could be affected as well as molecules of importance for transcription and translation (30, 31) . A role for altered transcription factors would be compatible with the influences on protein synthesis and insulin mRNA presently found. Further research is needed to elucidate these uncertainties.
Our results could be important for the future treatment of patients with noninsulin-dependent diabetes mellitus. Insulin secretion in these patients deteriorates with the duration of the disease (32); this could in part be due to glucotoxicity. Our results indicate a role for islet AGE formation in glucotoxicity. Theoretically, AGE formation could be even more important than indicated by our results, as a negative effect of circulating AGE on B cells was not tested and therefore cannot be ruled out. In this context it should be mentioned that we have also performed in vivo studies showing a beneficial effect of AG on islet graft function in a rat transplantation model (33) . If AGE formation plays a role in glucotoxicity toward B cells, it may be possible to treat patients with drugs such as AG to avoid or retard the deterioration of B cell function. In conclusion, our results provide evidence for glucoseinduced formation of AGEs in pancreatic islets and for the inhibition of such formation by AG. Moreover, in high glucose-cultured islets, AG time-dependently increases B cell secretion and insulin biosynthesis. These observations indicate a negative role of AGEs in B cell function. Groups of islets were cultured in RPMI 1640 for 1 or 6 weeks. Insulin content was measured from islets that had been exposed to 3.3 mM glucose in final incubations after each culture period. Data are the mean Ϯ SEM of 10 -20 observations. a P Ͻ 0.05 vs. the value without AG.
